Arkolith/Insider Trading/CMRA/Form 4

Cherington Charles

10% OwnerComera Life Sciences Holdings, Inc. (CMRA) · full profile →Form 4 · filed Sep 11, 2023
Net Buying
Open-Market Buys
$1.0M
Open-Market Sells
$0
Net Open-Market Flow
$1.0M
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 11, 2023Buy(P)2.1M$0.51$1.0M5.8M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 11, 2023Buy(P)5.1M—$05.1M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-23-099800) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML